Centene (CNC) Competitors $33.06 -0.25 (-0.75%) Closing price 07/7/2025 03:59 PM EasternExtended Trading$33.03 -0.03 (-0.09%) As of 07/7/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock CNC vs. ELV, MOH, SEM, CI, HUM, UNH, JYNT, AEMD, BMY, and HCAShould you be buying Centene stock or one of its competitors? The main competitors of Centene include Elevance Health (ELV), Molina Healthcare (MOH), Select Medical (SEM), Cigna Group (CI), Humana (HUM), UnitedHealth Group (UNH), Joint (JYNT), Aethlon Medical (AEMD), Bristol Myers Squibb (BMY), and HCA Healthcare (HCA). These companies are all part of the "medical" sector. Centene vs. Its Competitors Elevance Health Molina Healthcare Select Medical Cigna Group Humana UnitedHealth Group Joint Aethlon Medical Bristol Myers Squibb HCA Healthcare Centene (NYSE:CNC) and Elevance Health (NYSE:ELV) are both large-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, dividends, profitability, earnings, risk, analyst recommendations, media sentiment and institutional ownership. Does the media refer more to CNC or ELV? In the previous week, Centene had 43 more articles in the media than Elevance Health. MarketBeat recorded 102 mentions for Centene and 59 mentions for Elevance Health. Elevance Health's average media sentiment score of 0.75 beat Centene's score of -0.06 indicating that Elevance Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Centene 18 Very Positive mention(s) 12 Positive mention(s) 32 Neutral mention(s) 22 Negative mention(s) 9 Very Negative mention(s) Neutral Elevance Health 22 Very Positive mention(s) 4 Positive mention(s) 29 Neutral mention(s) 3 Negative mention(s) 1 Very Negative mention(s) Positive Is CNC or ELV more profitable? Elevance Health has a net margin of 3.23% compared to Centene's net margin of 2.04%. Elevance Health's return on equity of 18.61% beat Centene's return on equity.Company Net Margins Return on Equity Return on Assets Centene2.04% 14.56% 4.75% Elevance Health 3.23%18.61%6.80% Which has more volatility & risk, CNC or ELV? Centene has a beta of 0.44, meaning that its share price is 56% less volatile than the S&P 500. Comparatively, Elevance Health has a beta of 0.6, meaning that its share price is 40% less volatile than the S&P 500. Do analysts recommend CNC or ELV? Centene currently has a consensus target price of $68.87, suggesting a potential upside of 108.31%. Elevance Health has a consensus target price of $498.87, suggesting a potential upside of 43.87%. Given Centene's higher probable upside, equities research analysts clearly believe Centene is more favorable than Elevance Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Centene 0 Sell rating(s) 10 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.41Elevance Health 0 Sell rating(s) 4 Hold rating(s) 12 Buy rating(s) 0 Strong Buy rating(s) 2.75 Do institutionals and insiders hold more shares of CNC or ELV? 93.6% of Centene shares are held by institutional investors. Comparatively, 89.2% of Elevance Health shares are held by institutional investors. 0.4% of Centene shares are held by insiders. Comparatively, 0.3% of Elevance Health shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Which has preferable valuation and earnings, CNC or ELV? Elevance Health has higher revenue and earnings than Centene. Centene is trading at a lower price-to-earnings ratio than Elevance Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCentene$169.28B0.10$3.31B$6.714.93Elevance Health$177.01B0.44$5.98B$25.6313.53 SummaryElevance Health beats Centene on 12 of the 16 factors compared between the two stocks. Get Centene News Delivered to You Automatically Sign up to receive the latest news and ratings for CNC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CNC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CNC vs. The Competition Export to ExcelMetricCenteneMED IndustryMedical SectorNYSE ExchangeMarket Cap$16.58B$42.60B$5.52B$20.71BDividend YieldN/A111.92%5.24%3.72%P/E Ratio4.939.2627.2627.80Price / Sales0.101.35381.2547.18Price / Cash3.379.2226.2118.22Price / Book0.632.697.944.59Net Income$3.31B$2.64B$3.17B$982.91M7 Day Performance-41.67%-9.63%1.80%0.65%1 Month Performance-40.07%-13.28%1.28%4.26%1 Year Performance-50.07%-31.20%33.57%13.93% Centene Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CNCCentene4.9692 of 5 stars$33.06-0.8%$68.87+108.3%-50.2%$16.58B$169.28B4.9360,500Trending NewsHigh Trading VolumeELVElevance Health4.9684 of 5 stars$389.42+2.1%$498.87+28.1%-34.6%$87.98B$183.12B15.19102,300Trending NewsMOHMolina Healthcare4.9831 of 5 stars$297.09+0.0%$364.21+22.6%-20.5%$16.10B$40.65B14.3518,000Trending NewsSEMSelect Medical5 of 5 stars$15.19-0.5%$26.00+71.2%-58.9%$1.95B$5.19B11.3444,100Positive NewsCICigna Group4.9569 of 5 stars$330.12+1.2%$380.39+15.2%-1.8%$88.19B$254.47B18.2871,300Positive NewsHigh Trading VolumeHUMHumana4.6169 of 5 stars$244.30+1.0%$280.76+14.9%-35.7%$29.49B$120.26B17.2867,100UNHUnitedHealth Group4.9985 of 5 stars$311.89+0.9%$415.57+33.2%-37.8%$282.93B$400.28B13.06400,000Positive NewsUpcoming EarningsJYNTJoint3.0088 of 5 stars$11.54+1.1%$15.50+34.3%-11.1%$176.60M$52.79M-19.90320News CoverageAEMDAethlon Medical2.4842 of 5 stars$1.20-4.0%$56.00+4,566.7%-67.5%$3.11M$570K-0.0910News CoverageAnalyst ForecastHigh Trading VolumeBMYBristol Myers Squibb4.8983 of 5 stars$46.35flat$58.00+25.1%+17.2%$94.33B$48.30B17.3634,300Positive NewsHCAHCA Healthcare4.8111 of 5 stars$383.21+1.0%$395.71+3.3%+18.2%$92.19B$70.60B17.04294,000Positive NewsAnalyst Upgrade Related Companies and Tools Related Companies ELV Alternatives MOH Alternatives SEM Alternatives CI Alternatives HUM Alternatives UNH Alternatives JYNT Alternatives AEMD Alternatives BMY Alternatives HCA Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:CNC) was last updated on 7/8/2025 by MarketBeat.com Staff From Our PartnersEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredF1 Engineering Powers This Electric Marine MotorThe future of marine propulsion has arrived - powered by F-1 grade engineering. In collaboration with McLar...The Tomorrow Investor | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredInstant Cash (in 4 clicks)Since 1973, Wall Street has quietly used a strange little pricing quirk to cash flow billions. Now, for the...Awesomely, LLC | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Centene Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Centene With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.